• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥美拉唑对氯氮平代谢影响的回顾性评估。

Retrospective evaluation of the effect of omeprazole on clozapine metabolism.

作者信息

Mookhoek Evert J, Loonen Anton J M

机构信息

Deltabouman Psychiatric Teaching Hospital, PO Box 800, 3170 DZ Poortugaal, The Netherlands.

出版信息

Pharm World Sci. 2004 Jun;26(3):180-2. doi: 10.1023/b:phar.0000026808.97403.05.

DOI:10.1023/b:phar.0000026808.97403.05
PMID:15230368
Abstract

OBJECTIVE

To study the effect of the replacement of omeprazole by pantoprazole on clozapine metabolism in 13 psychiatric patients, who used both clozapine and omeprazole.

METHOD

Retrospective study of the medical files.

RESULTS

In comparison to smokers, a significant rise of the serum clozapine levels was observed in all non-smoking patients, whilst the daily dose of clozapine remained unchanged. This effect was probably caused by the discontinuation of enzyme induction of the cytochrome P450 enzyme 1A2 by omeprazole in non-smokers, whereas CYP1A2 remained induced in patients who smoked.

CONCLUSION

Omeprazole only influenced clozapine metabolism in non-smokers. In none of the patients an adjustment of the clozapine dose was required.

摘要

目的

研究在13名同时使用氯氮平和奥美拉唑的精神科患者中,用泮托拉唑替代奥美拉唑对氯氮平代谢的影响。

方法

对病历进行回顾性研究。

结果

与吸烟者相比,所有非吸烟患者的血清氯氮平水平显著升高,而氯氮平的日剂量保持不变。这种效应可能是由于奥美拉唑在非吸烟者中停止了细胞色素P450酶1A2的酶诱导作用,而在吸烟患者中CYP1A2仍被诱导。

结论

奥美拉唑仅影响非吸烟者的氯氮平代谢。所有患者均无需调整氯氮平剂量。

相似文献

1
Retrospective evaluation of the effect of omeprazole on clozapine metabolism.奥美拉唑对氯氮平代谢影响的回顾性评估。
Pharm World Sci. 2004 Jun;26(3):180-2. doi: 10.1023/b:phar.0000026808.97403.05.
2
Apparent anaphylaxis associated with pantoprazole.与泮托拉唑相关的明显过敏反应。
Am J Health Syst Pharm. 2005 Jul 1;62(13):1388-9. doi: 10.2146/ajhp040375.
3
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.美国食品药品监督管理局报告的在使用奥美拉唑、兰索拉唑和泮托拉唑治疗期间发生的不良事件及药物相互作用总结。
Aliment Pharmacol Ther. 2003 Apr;17(8):1015-9. doi: 10.1046/j.1365-2036.2003.01550.x.
4
Recurrent anaphylaxis linked to pantoprazole.与泮托拉唑相关的复发性过敏反应。
J Allergy Clin Immunol. 2004 Oct;114(4):975-7. doi: 10.1016/j.jaci.2004.05.068.
5
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.幽门螺杆菌根除治疗对13C氨基比林呼气试验的影响:含奥美拉唑、兰索拉唑或泮托拉唑方案的比较。
Am J Gastroenterol. 2000 Oct;95(10):2762-7. doi: 10.1111/j.1572-0241.2000.03184.x.
6
Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.泮托拉唑与奥美拉唑治疗急性十二指肠溃疡的双盲比较
Eur J Gastroenterol Hepatol. 1995 May;7(5):407-10.
7
Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.
J Clin Psychopharmacol. 2004 Oct;24(5):568-71. doi: 10.1097/01.jcp.0000139756.58092.d8.
8
Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.泮托拉唑与奥美拉唑治疗反流性食管炎:一项欧洲多中心研究。
Aliment Pharmacol Ther. 1995 Dec;9(6):667-71. doi: 10.1111/j.1365-2036.1995.tb00437.x.
9
Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.奥美拉唑、兰索拉唑、泮托拉唑和雷贝拉唑治疗酸相关性疾病的疗效评估。
J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. doi: 10.1016/s1086-5802(16)31036-1.
10
[Drug interactions. Proton pump inhibitors II].[药物相互作用。质子泵抑制剂II]
Internist (Berl). 1998 Sep;39(9):978-9.

引用本文的文献

1
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.致美国食品药品监督管理局的信:提议对美国氯氮平药品说明书进行重大修改,全球氯氮平专家提供支持。第一部分:药代动力学文献综述及提议的修改内容。
J Clin Psychopharmacol. 2025;45(3):179-196. doi: 10.1097/JCP.0000000000001987. Epub 2025 Apr 9.
2
Infections associated with clozapine: a pharmacovigilance study using VigiBase.氯氮平相关感染:一项使用VigiBase的药物警戒研究。
Front Pharmacol. 2023 Oct 2;14:1260915. doi: 10.3389/fphar.2023.1260915. eCollection 2023.
3

本文引用的文献

1
Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.接受精神药物治疗患者的吸烟情况:药代动力学视角
CNS Drugs. 2001;15(6):469-94. doi: 10.2165/00023210-200115060-00005.
2
Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients.氯氮平在吸烟的精神分裂症患者中的血清浓度低于不吸烟的精神分裂症患者。
Pharmacol Toxicol. 1999 Nov;85(5):244-6. doi: 10.1111/j.1600-0773.1999.tb02016.x.
3
Review article: drug interactions with agents used to treat acid-related diseases.综述文章:与用于治疗酸相关性疾病的药物的药物相互作用
Clozapine in primary care.
初级保健中的氯氮平。
Aust Prescr. 2017 Dec;40(6):231-236. doi: 10.18773/austprescr.2017.067. Epub 2017 Dec 4.
4
Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine.质子泵抑制剂奥美拉唑和泮托拉唑对文拉法辛细胞色素 P450 介导的代谢的影响。
Clin Pharmacokinet. 2018 Jun;57(6):729-737. doi: 10.1007/s40262-017-0591-8.
5
Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management.奥美拉唑药物动力学药物相互作用特征及其不良后果与临床风险管理。
Ther Clin Risk Manag. 2013;9:259-71. doi: 10.2147/TCRM.S43151. Epub 2013 May 27.
6
Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies?氯氮平血药浓度变化的混杂因素:与质子泵抑制剂的药物相互作用还是感染性病因?
Eur J Clin Pharmacol. 2011 May;67(5):533-4. doi: 10.1007/s00228-010-0925-z. Epub 2010 Nov 6.
Aliment Pharmacol Ther. 1999 Aug;13 Suppl 3:18-26. doi: 10.1046/j.1365-2036.1999.00021.x.
4
Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.质子泵抑制剂兰索拉唑、奥美拉唑和泮托拉唑与其他药物的代谢相互作用。
Eur J Gastroenterol Hepatol. 1996 Oct;8 Suppl 1:S21-5. doi: 10.1097/00042737-199610001-00005.
5
Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry.精神科中的药物代谢酶与治疗药物监测
Ther Drug Monit. 1996 Aug;18(4):393-6. doi: 10.1097/00007691-199608000-00014.